Advisory Research’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-38,326
| Closed | -$1.31M | – | 483 |
|
|
2023
Q3 | $1.31M | Sell |
38,326
-6,096
| -14% | -$208K | 0.18% | 157 |
|
|
2023
Q2 | $1.71M | Buy |
44,422
+17,582
| +66% | +$677K | 0.22% | 126 |
|
|
2023
Q1 | $961K | Sell |
26,840
-5,891
| -18% | -$211K | 0.16% | 159 |
|
|
2022
Q4 | $1.29M | Sell |
32,731
-3,707
| -10% | -$146K | 0.12% | 126 |
|
|
2022
Q3 | $1.32M | Buy |
36,438
+1,438
| +4% | +$51.9K | 0.13% | 126 |
|
|
2022
Q2 | $1.06M | Buy |
+35,000
| New | +$1.06M | 0.1% | 152 |
|